-Amyloid in Alzheimer's disease: friend or foe?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1378, 2003-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multi-Compartment Compliance Aids: Friend or Foe?

By WalshBScH Kate

Drugs & Aging, Vol. 29, Iss. 3, 2012-03 ,pp. : 249-250

Adis International

Access to resources Recommend Favorite

Alzheimer's disease vaccine: Cerebral amyloid angiopathy and microhaemorrhage in an elderly patient?: case report

Reactions Weekly, Vol. 1, Iss. 1317, 2010-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Is there a Future for Cyclo-Oxygenase Inhibitors in Alzheimer's Disease?

By Ho Lap Qin Weiping Stetka Breton S. Pasinetti Giulio M.

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 85-98

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors in Alzheimer's Disease: Are they Worth the Cost?

By Whitehouse P.J.

CNS Drugs, Vol. 11, Iss. 3, 1999-03 ,pp. : 167-173

Adis International

Access to resources Recommend Favorite

Donepezil - benefits extend to advanced Alzheimer's disease?

Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite